Insider Shareholders with Direct Ownership of X4 Pharmaceuticals, Inc (XFOR)
This section provides a comprehensive overview of the insiders with direct ownership of X4 Pharmaceuticals, Inc (XFOR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
X4 Pharmaceuticals, Inc Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Paula Ragan
President and CEO |
987,151 | 509,406 | 765,068 $443,739 | 31 |
Mar 11, 2024
Reduced 6.1%
|
722,179 | 0 | 722,179 $418,863 | 1 |
Nov 20, 2017
Added 50.0%
|
|
Mary Di Biase
Chief Operating Officer |
362,645 | 131,695 | 291,752 $169,216 | 17 |
Mar 11, 2024
Reduced 5.02%
|
Arthur Taveras
Chief Scientific Officer |
335,680 | 101,379 | 234,301 $135,894 | 9 |
Mar 11, 2024
Reduced 5.73%
|
Murray Stewart
Director |
321,560 | 130,056 | 191,504 $111,072 | 4 |
Jun 10, 2024
Added 19.03%
|
Derek M Meisner
Chief Legal Officer |
177,728 | 49,239 | 145,155 $84,189 | 11 |
Aug 17, 2022
Reduced 5.43%
|
Keith Woods
Director |
135,000 | 0 | 135,000 $78,300 | 2 |
Jun 10, 2024
Added 25.0%
|
Michael S Wyzga
Director |
121,667 | 0 | 121,667 $70,566 | 4 |
Jun 10, 2024
Added 27.0%
|
Diego Cadavid
Chief Medical Officer |
105,035 | 928 | 104,107 $60,382 | 3 |
Mar 01, 2022
Added 48.23%
|
David W J Mcgirr
Director |
96,667 | 0 | 96,667 $56,066 | 3 |
Jun 10, 2024
Added 31.76%
|
Alison Frances Lawton
Director |
96,667 | 0 | 96,667 $56,066 | 3 |
Jun 10, 2024
Added 31.76%
|
Gary Bridger
Director |
96,667 | 0 | 96,667 $56,066 | 3 |
Jun 10, 2024
Added 31.76%
|
William Aliski
Director |
96,667 | 0 | 96,667 $56,066 | 3 |
Jun 10, 2024
Added 31.76%
|
Francoise De Craecker
Director |
96,667 | 0 | 96,667 $56,066 | 3 |
Jun 10, 2024
Added 31.76%
|
Mark Baldry
Chief Commercial Officer |
34,947 | 10,257 | 24,690 $14,320 | 2 |
Nov 01, 2023
Reduced 29.35%
|
Adam S. Mostafa
Chief Financial Officer |
451,308 | 480,897 | 0 $0 | 22 |
Mar 11, 2024
Reduced 100.0%
|